Evidence map›Paper›PMID 36507937›Full record

ReviewMetabolic brain disease2023

Remote monitoring of cognition in cirrhosis and encephalopathy: future opportunity and challenge.

Adam P Buckholz, Russell Rosenblatt

Open access · bronzeAbstract readReview
In one paragraph

Review in Metabolic brain disease, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Adam P BuckholzNewYork-Presbyterian/Weill Cornell Medical College Division of Gastroenterology and Hepatology, New York, NY, 10021, USA.ORCID http://orcid.org/0000-0002-0068-353X
Russell RosenblattNewYork-Presbyterian/Weill Cornell Medical College Division of Gastroenterology and Hepatology, New York, NY, 10021, USA. rur9017@med.cornell.edu.ORCID http://orcid.org/0000-0003-3981-7053
Cornell University · US

Funding

Multidisciplinary Research Training in Gastroenterology and HepatologyT32DK116970 · NIDDK · WEILL MEDICAL COLL OF CORNELL UNIV · PI Randy S Longman · 2019 to 2026
$2.3M
NIDDK NIH HHS T32 DK116970
6 · The paper itself

Abstract

Hepatic Encephalopathy (HE) is a critically important complication of chronic liver disease and portal hypertension, but especially in early covert stages remains underdiagnosed and a common cause of hospitalization and morbidity. Defined by often subtle neuropsychiatric changes, significant cognitive deficits have been extensively described. While traditional methods of assessment remain underutilized in practice and subject to significant confounding with other diseases, mobile technology has emerged as a potential future tool to provide simple and dynamic cognitive assessments. This review discusses the proliferation of cognitive assessment tools, describing possible applications in encephalopathy and the challenges such an implementation may face. There are significant potential advantages to assessing cognition in real time in order to aid early detection and intervention and provide a more realistic measurement of real-world function. Despite this, there are issues with reliability, privacy, applicability and more which must be addressed prior to wide proliferation and acceptance for clinical use. Regardless, the rapid uptake of mobile technology in healthcare is likely to have significant implications for the future management of encephalopathy and liver disease at large.

Indexed as

Hepatic EncephalopathyLiver DiseasesCognitionHumansLiver CirrhosisReproducibility of ResultsCognitionEncephalopathyLiver diseaseMobile technologyPortal hypertensionRemote monitoring

Identifiers

PMID36507937
PMCPMC9743123
OpenAlexW4311825944

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.